Shenzhen Kangtai Biological Products Co Ltd Sustainability Reports
The company focuses on the research, development, production, and sale of human vaccines. It specializes in biopharmaceutical innovations including polyvalent, genetic engineering, and inactivated vaccine varieties.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
LEI: 300300DTC3W6PCLFRJ05
FIGI: BBG001SKXCC6
16 reports from 2016 to 2025
- Shenzhen Kangtai Biological Products Co Ltd 2025 Annual Report
- Shenzhen Kangtai Biological Products Co Ltd 2024 Annual Report
- Shenzhen Kangtai Biological Products Co Ltd 2024 Environmental, Social and Governance (ESG) Report
- Shenzhen Kangtai Biological Products Co Ltd 2023 Social Responsibility Report and ESG Report
- Shenzhen Kangtai Biological Products Co Ltd 2023 Annual Report